Literature DB >> 25555480

A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission.

Minoru Kojima1, Naoya Nakamura, Miharu Yabe, Mami Tokunaka, Yara Yukie Kikuti, Tomoki Kikuchi, Hiromichi Murayama, Makiko Moriuchi, Kosuke Tsuboi, Yoshiaki Ogawa, Kiyoshi Ando.   

Abstract

We report a case of HIV-negative Burkitt lymphoma (BL) that relapsed 9 years after complete remission. We performed a polymerase chain reaction analysis of three regions of the VDJ junction of the immunoglobulin heavy chain (IGH) gene and compared the clonality of the first and second BL lesions, which were found to be clonally distinct. The patient received the R-Hyper CVAD/R-MA regimen; however, leukoencephalopathy subsequently developed due to the effect of cytarabine, and the regimen was changed to R-IVAM. The patient achieved complete remission and received high-dose chemotherapy following autologous stem cell transplantation. He maintained the complete remission for 72 months after transplantation. Given this outcome, we suggest that clonally distinct relapse of HIV-negative BL may exhibit a good prognosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25555480     DOI: 10.1007/s12185-014-1729-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  15 in total

1.  A clonally distinct recurrence of Burkitt's lymphoma at 15 years.

Authors:  J Lister; J A Miklos; S H Swerdlow; D W Bahler
Journal:  Blood       Date:  1996-08-15       Impact factor: 22.113

Review 2.  Etiology of Burkitt's lymphoma--an alternative hypothesis to a vectored virus.

Authors:  D P Burkitt
Journal:  J Natl Cancer Inst       Date:  1969-01       Impact factor: 13.506

3.  Relapse patterns in Burkitt's lymphoma.

Authors:  J L Ziegler; A Z Bluming; L Fass; R H Morrow
Journal:  Cancer Res       Date:  1972-06       Impact factor: 12.701

4.  Clonal analysis by polymerase chain reaction of B-cell lymphoma with late relapse: a report of five cases.

Authors:  R Nishiuchi; T Yoshino; N Teramoto; I Sakuma; K Hayashi; S Nakamura; Y Seino; T Akagi
Journal:  Cancer       Date:  1996-02-15       Impact factor: 6.860

5.  An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults.

Authors:  I T Magrath; C Janus; B K Edwards; R Spiegel; E S Jaffe; C W Berard; J Miliauskas; K Morris; R Barnwell
Journal:  Blood       Date:  1984-05       Impact factor: 22.113

6.  Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.

Authors:  Catherine Patte; Anne Auperin; Mary Gerrard; Jean Michon; Ross Pinkerton; Richard Sposto; Claire Weston; Martine Raphael; Sherrie L Perkins; Keith McCarthy; Mitchell S Cairo
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

Review 7.  Second primary lymphoma or recurrence: a dilemma solved by VDJ rearrangement analysis.

Authors:  Massimo Libra; Valli De Re; Annunziata Gloghini; Patrick Michael Navolanic; Antonino Carbone; Mauro Boiocchi
Journal:  Leuk Lymphoma       Date:  2004-08

8.  Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols.

Authors:  C Soussain; C Patte; M Ostronoff; A Delmer; F Rigal-Huguet; N Cambier; P Y Leprisé; S François; P Cony-Makhoul; J L Harousseau
Journal:  Blood       Date:  1995-02-01       Impact factor: 22.113

9.  Outcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol.

Authors:  Akira Kikuchi; Tetsuya Mori; Jun-Ichiro Fujimoto; Masaaki Kumagai; Shosuke Sunami; Yuri Okimoto; Masahiro Tsuchida
Journal:  Leuk Lymphoma       Date:  2008-04

10.  Low-intensity therapy in adults with Burkitt's lymphoma.

Authors:  Kieron Dunleavy; Stefania Pittaluga; Margaret Shovlin; Seth M Steinberg; Diane Cole; Cliona Grant; Brigitte Widemann; Louis M Staudt; Elaine S Jaffe; Richard F Little; Wyndham H Wilson
Journal:  N Engl J Med       Date:  2013-11-14       Impact factor: 91.245

View more
  1 in total

1.  A recurrent clonally distinct Burkitt lymphoma case highlights genetic key events contributing to oncogenesis.

Authors:  Dominique Penther; Pierre-Julien Viailly; Sylvain Latour; Pascaline Etancelin; Elodie Bohers; Hélène Vellemans; Vincent Camus; Anne Lise Menard; Sophie Coutant; Hélène Lanic; Emilie Lemasle; Fanny Drieux; Liana Veresezan; Philippe Ruminy; Anna Raimbault; Jean Soulier; Thierry Frebourg; Hervé Tilly; Fabrice Jardin
Journal:  Genes Chromosomes Cancer       Date:  2019-03-27       Impact factor: 5.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.